hsa-mir-564: Hsa-mir-564 is a microRNA that has been identified in various studies across different contexts. In one study, hsa-mir-564 was found to be upregulated in exosomes in the culture medium of the UVA group, indicating its potential role in response to UVA radiation [PMC7719707]. Another study identified hsa-mir-564 as part of a seven-miRNA signature associated with schizophrenia, where its expression was correlated with negative symptoms and neurocognitive performance [PMC3726785]. In a comparison between milk cells and fat cells, hsa-mir-564 was found to be higher in fat cells [PMC4745068]. However, it should be noted that hsa-mir-564 was not detected in certain samples and was excluded from subsequent analysis [PMC4478345]. Additionally, hsa-mir-564 has been implicated in breast cancer progression and tamoxifen resistance [PMC5013276][PMC2970572]. In the context of type 1 diabetes (T1D), hsa-mir-564 was identified as part of a regulatory network involving target genes and transcription factors associated with T1D development [PMC8028841]. Furthermore, studies have shown that hsa-mir-564 is upregulated in certain conditions such as liver cancer cells (L02/HBx) and preterm infants with schizophrenia [PMC5352919][PMC5068884][PMC8049460]. Overall, these studies highlight the potential role of hsa-mir-564 across different biological contexts.